Characterization of Neoantigen-Specific T Cells in Cancer Resistant to Immune Checkpoint Therapies

Leveraging the use of mass cytometry combined with multiplex major histocompatibility complex class I tetramer staining, researchers screened and identified tumor neoantigen–specific CD8+ T cells in the Lewis Lung carcinoma tumor model.